Leeds-Manchester Clinical

Frailty assessment using imaging-derived body composition analysis to inform personalised anal cancer treatment – reverse and forward translation within the PLATO trial platforms

Multimodal analysis of the locoregional immune response to improve management and outcomes in patients with oesophagogastric cancer

Is the cancer-associated microbiome a key determinant of the immune response to bowel cancer or are immunogenetic lesions more important?